Direct knowledge transfer to clinical care: Patients come from all over Germany to the outpatient clinic for cancer predisposition syndromes at the MHH Children's Hospital.

We report on the creation of a scientific space for clinical cancer research in Lower Saxony and draw attention to new projects that have been initiated through legacies. The Clinical Research Department at the CCC introduces itself and its new team. You will also find sporting news: the Hanover team triumphed at the "Rowing against Cancer" charity regatta in Halle. Furthermore, a training course for more safety in pediatric oncology received the Lohfert Prize 2024.

listen now

MHH cooperation project PRETTY develops prediction model for individual risk of side effects after stem cell transplantation

What are risk factors and how can breast cancer be detected early? Dr. Marlene Röttger, a specialist in the Clinical Department of Gynecology and Obstetrics at the MHH, explains what to look out for during a breast self-examination.

The first study to date to investigate the risk of cancer in mosaic RASopathies due to disease-causing variants in the HRAS or KRAS genes shows how important close-meshed early detection of cancer is.

SICKO interprofessional team training ensures greater safety and higher quality of treatment - award at the Healthcare Industry Congress

Hanover team triumphs at charity regatta in Halle

It is National Cancer Prevention Week from September 9 to 15: Together with the DKH and the DKFZ, we are drawing attention to the cancer risk factor of physical inactivity.

Online offer starts on August 21, 2024 and is aimed at people without basic medical training to support cancer patients and their relatives.

We report on research projects on blood cancer, study results on Fanconi anemia and on a new AI tool for diagnosing leukemia. We also introduce one of our assistant physicians who is being supported by the Mildred Scheel Postdoctoral Program of German Cancer Aid. In recent months, we also held a panel discussion on physician-patient discussions, the 38th Hanover Self-Help Day and the Klaus Bahlsen Center celebrated reunions with 45 former participants of the group program.

"Interdisciplinary Center for Clinical Cancer Research" (IZKKF) of the CCC-N strengthens young scientists and access to clinical trials.

Significant progress in personalized medicine: MHH researchers combine comprehensive clinical data in an easy-to-use platform

Topics in this issue include the continued funding of our CCC-N as an Oncology Center of Excellence by German Cancer Aid, the launch of the IMAGINE Lower Saxony project, the awarding of the Johann-Georg-Zimmermann Prize for outstanding cancer research and the awarding of the Federal Cross of Merit to Andrea Hahne, full-time officer of the BRCA network and former patient representative at the CCC-N.

Klaus Bahlsen Centre organizes day program for 45 former participants

The Comprehensive Cancer Center Niedersachsen (CCC-N) - a cooperation between Hannover Medical School (MHH) and the University Medical Center Göttingen (UMG) - is being funded for a further four years with 4.8 million euros as an Oncological Center of Excellence by German Cancer Aid (DKH). DKH supports a total of 14 centers of excellence in oncology throughout Germany.

The MHH plus Foundation honors Prof. Dr. Michael Bamberg and Dr. Franziska Blaeschke with the Zimmermann Prize and Medal

The RACOON-RESCUE project, led by the MHH, aims to automatically analyze image data from CT and MRI and find new image-based features in order to be able to more reliably assess the stage of disease in children and adolescents with non-Hodgkin's lymphoma.

Result of an international cohort study by MHH researchers

Good physician-patient communication is crucial for the healthcare of those affected. It can alleviate fears and promote the healing process and quality of life. But how can good Communications be achieved? This question was discussed on Tuesday, May 14, 2024 in the panel discussion "Doctor-Patient Communications in Cancer Medicine".

How much sun can my skin take? And how can I protect myself? Tips from our dermatologist and senior physician Kai-Christian Klespe from the Skin Tumor Center.

The MHH joint project TARGET-MPN is investigating why myeloproliferative neoplasms (MPN) evade targeted therapy and develop into leukemias.

Clinical Department of the MHH uses interstitial brachytherapy for malignant cervical tumors.

Funded with eight million euros: The MHH is leading the RESOLVE research network, which is on the trail of the "gold standard" in AML and CLL treatment.

Topics include an interview with Prof. Dr. Schmelzle on oncological surgery at the MHH, a new European initiative for the prevention of cancer, initial study successes with combined cell therapy and vaccination against cancer and the meeting of the "Young DEGRO" in Hanover. We also introduce you to our newly elected Board of Directors and inform you about upcoming events at the CCC.

A research team at the MHH is comparing changes in natural killer cells of the innate immune defense in chronic hepatitis C patients as a risk factor for the later development of hepatocellular carcinoma (HCC).

MHH haematologist Dr. Florian Perner receives 2.2 million euros from the Emmy Noether Program of the German Research Foundation (DFG) for his research into epigenetic changes in blood stem cells and their role in the development of blood cancer.

Topics include our new "Treatment development platform", the CCC-N being awarded the Lower Saxony Cancer Society's sponsorship prize and upcoming events such as the "Young DEGRO" spring symposium in Hanover and the CCC-N Pancreatic Cancer Research Congress in Göttingen.

MHH is a project partner in the field of genetic (cancer) predisposition

Excellent: CCC training for lay people without basic medical training to support cancer patients and their relatives

Broadcast: Hallo Niedersachsen | 04.02.2024 | 19:30 | 4 min | Available until 04.02.2026

On World Cancer Day, Jessica Weiner tells her story. She wants to encourage other cancer sufferers, including those who, like her, suffer from a rare disease.

The MHH Cancer Center is taking part in the International Union Against Cancer (UICC) day of action and will be providing information on cancer prevention and early detection as well as the latest developments in the fields of diagnosis, treatment and aftercare on February 7 and 8 at the Aufhof in Hanover's city centre.

The Tumor Foundation of the MHH supports five projects from the Comprehensive Cancer Center